ArcticZymes Technologies ASA (OSL:AZT)

Norway flag Norway · Delayed Price · Currency is NOK
19.90
-1.10 (-5.24%)
At close: Dec 5, 2025
48.73%
Market Cap 1.02B
Revenue (ttm) 109.99M
Net Income (ttm) 7.20M
Shares Out 51.07M
EPS (ttm) 0.15
PE Ratio 133.99
Forward PE 53.97
Dividend n/a
Ex-Dividend Date n/a
Volume 91,991
Average Volume 46,430
Open 20.70
Previous Close 21.00
Day's Range 19.90 - 21.00
52-Week Range 13.00 - 31.40
Beta 0.37
RSI 30.63
Earnings Date Apr 29, 2026

About OSL:AZT

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing. The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1990
Employees 54
Stock Exchange Oslo Børs
Ticker Symbol AZT
Full Company Profile

Financial Performance

In 2024, OSL:AZT's revenue was 108.11 million, a decrease of -9.65% compared to the previous year's 119.65 million. Earnings were 8.47 million, a decrease of -56.40%.

Financial Statements

News

There is no news available yet.